Difference between revisions of "Bone sarcoma"
Jump to navigation
Jump to search
m (→Guidelines) |
m |
||
| Line 1: | Line 1: | ||
| − | + | <span id="BackToTop"></span> | |
| − | + | <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px; opacity:0.8; border-style: solid; border-color:DarkGray; border-width: 1px"> | |
| − | + | [[#top|Back to Top]] | |
| − | + | </div> | |
| − | + | {{#lst:Section editor transclusions|sarcoma}} | |
| − | |||
| − | |} | ||
{| class="wikitable" style="float:right; margin-right: 5px;" | {| class="wikitable" style="float:right; margin-right: 5px;" | ||
|- | |- | ||
Revision as of 01:01, 29 July 2022
0 regimens on this page
0 variants on this page
|
Note: this page is for subtype-nonspecific bone sarcoma regimens, and some subtypes with very few subtype-specific regimens. Please see the category page for links to other sarcoma types or use one of these links:
Guidelines
ESMO/EURACAN/GENTURIS/PaedCan
- 2021: Strauss et al. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Older
- 2018: Casali et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- 2014: Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
NCCN
Chondrosarcoma, all lines of therapy
- No standard chemotherapy for grades 1 to 3 conventional chondrosarcoma
- Mesenchymal chondrosarcoma has been treated with Ewing's sarcoma regimens
- Dedifferentiated chondrosarcoma has been treated with osteosarcoma regimens
Undifferentiated pleomorphic sarcoma (UPS) of bone, all lines of therapy
- Undifferentiated pleomorphic sarcoma (UPS) of bone has been treated with osteosarcoma regimens